Skip to main content
SpringerLink
Log in

Possibilities of in Silico Estimations for the Development of the Pharmaceutical Composition Phytoladaptogene Cytotoxic for Bladder Cancer Cells

  • Published:
Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry Aims and scope Submit manuscript

Abstract—

The priority direction of the pharmaceutical composition Phytoladaptogene (PLA) development based on the prediction of biological activity spectra for several secondary metabolites of medicinal plants using the PASS computer program and validation in vitro of the prediction result was determined. PLA is a complex of structurally diverse small organic compounds including biologically active substances of phytoadaptogenes (ginsenosides from Panax ginseng, rhodionin from Rhodiola rosea and others) compiled considering previously developed pharmaceutical compositions. Two variants of the pharmaceutical composition were studied—major (22 compounds) and minor (13 compounds) ones. The probability of activity exceeds the probability of inactivity for 1400 out of 1945 pharmacological effects and mechanisms predicted by PASS for the major version of PLA. The wide range of predicted activities is mainly due to the compounds' low structural similarity to each other. An in silico prediction indicates the possibilities of antitumor properties against bladder, stomach, colon, ovarian and cervical cancers both for minor and major PLA compositions. It was found that the highest probability values of activity are predicted for three mechanisms: Apoptosis agonist, Caspase 3 stimulant, and Transcription factor NF kappa B inhibitor. According to the PharmaExpert program, they are associated with the antitumor effect against bladder cancer. Experimental validation was performed in vitro on the human bladder cancer cell line RT-112. As a result of the MTT test the cytotoxicity of the PLA major variant was found to be higher than that of the minor one. In the in vitro experiments using two methods—double staining with annexin V and propidium iodide as well as detection of active caspase 3 in cells—the death of bladder cancer cells by the apoptosis mechanism was also confirmed. The data obtained correspond to the results of the prediction and indicate the major PLA composition advantages. Phytoladaptogene can become the basis for the development of a drug with antitumor activity against bladder cancer. Antitumor activity predicted by PASS for other cancers may be the subject of further studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.
Fig. 2.
Fig. 3.
Fig. 4.
Fig. 5.
Fig. 6.
Fig. 7.
Fig. 8.
Fig. 9.
Fig. 10.

Similar content being viewed by others

REFERENCES

  1. Rana, J.S., Khan, S.S., Lloyd-Jones, D.M., and Sidney, S., Journal of General Internal Medicine, 2020, 1–2.

  2. Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., and Jemal, A., CA: a Cancer Journal for Clinicians, 2018, vol. 68, no. 6, pp. 394–424.

    Google Scholar 

  3. Wang, S., Dong, G., and Sheng, C., Chemical Reviews, 2019, vol. 119, no. 6, pp. 4180–4220.

    Article  CAS  Google Scholar 

  4. Newman, D.J. and Cragg, G.M. Journal of Natural Products, 2020, vol. 83, no. 3, pp. 770–803.

    Article  Google Scholar 

  5. Bhanot, A., Sharma, R., and Noolvi, M.N., (2011) International Journal of Phytomedicine, vol. 3, no. 1, 09.

  6. Chen, Y., and Kirchmair, J., Molecular Informatics, 2020, vol. 39, no. 12, 2000171.

    Article  CAS  Google Scholar 

  7. Bocharova, O.A., Baryshnikova, M.A., Zajchik, B.C., Karpova, R.V., Bocharov, E.V., Vashakmadze, L.A., Kazeev, I.V., Kucheryanu, V.G., Kosorukov, V.S., Matveev, V.B., Stilidi, I.S., Rus. Patent no. 2747147, registration date April 28, 2021.

  8. Bocharova, O.A., Karpova, R.V. Bocharov, E.V., Vershinskaya, A.A., Baryshnikova, M.A., Kazeev, I.V., Kucheryanu, V.G., and Kiselevskiy, M.V., Rus. Bioter. Jurn., 2020, vol. 19, vol. 4, pp. 12–20. https://doi.org/10.17650/1726-9784-2019-19-2-13-2153-58

  9. Poroikov, V.V., Biomeditsinskaya Khimiya, 2020, vol. 66, no. 1, pp. 30−41.

    Article  CAS  Google Scholar 

  10. Filimonov, D.A., Druzhilovskiy, D.S., Lagunin, A.A., Gloriozova, T.A., Rudik, A.V., Dmitriev, A.V., and Poroikov, V.V., Biomedical Chemistry: Research and Methods, 2018, vol. 1, no. 1, e00004.

    Google Scholar 

  11. Filimonov, D., Poroikov, V., Borodina, Y., and Gloriozova, T., Journal of Chemical Information and Computer Sciences, 1999, vol. 39, no. 4, pp. 666–670.

    Article  CAS  Google Scholar 

  12. Lagunin, A.A., Goel, R.K., Gawande, D.Y., Pahwa, P., Gloriozova, T.A., Dmitriev, A.V., and Poroikov, V.V., Natural Product Reports, 2014, vol. 31, no. 11, pp. 1585–1611.

    Article  CAS  Google Scholar 

  13. Goel, R.K., Gawande, D.Y., Lagunin, A.A., and Poroikov, V.V., SAR and QSAR in Environmental Research, 2018, vol. 29, no. 1, pp. 69–81.

    Article  CAS  Google Scholar 

  14. Mosmann, T., Journal of Immunological Methods, 1983, vol. 65, nos. 1–2, pp. 55–63.

    Article  CAS  Google Scholar 

Download references

Funding

The work was performed in the framework of the Russian Federation Fundamental Research Program for the long-term period for 2021−2030.

Author information

Authors and Affiliations

  1. Institute of Biomedical Chemistry, ul. Pogodinskaya 10, Bldg. 8, 119121, Moscow, Russia

    N. S. Ionov, P. V. Pogodin, A. A. Lagunin, D. A. Filimonov & V. V. Poroikov

  2. Blokhin National Medical Research Center of Oncology, Kashirskoe shosse 24, 115478, Moscow, Russia

    M. A. Baryshnikova, E. V. Bocharov, R. V. Karpova, V. S. Kosorukov, I. S. Stilidi, V. B. Matveev & O. A. Bocharova

Authors
  1. N. S. Ionov
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. A. Baryshnikova
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. V. Bocharov
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P. V. Pogodin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. A. Lagunin
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. D. A. Filimonov
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. R. V. Karpova
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. V. S. Kosorukov
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. I. S. Stilidi
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. V. B. Matveev
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. O. A. Bocharova
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. V. V. Poroikov
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to N. S. Ionov.

Ethics declarations

CONFLICT OF INTEREST

The authors declare that they have no conflict of interest.

COMPLIANCE WITH ETHICAL STANDARDS

This article does not contain any research involving humans or the use of animals as objects.

Additional information

The article was translated by the author (N.S. Ionov).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ionov, N.S., Baryshnikova, M.A., Bocharov, E.V. et al. Possibilities of in Silico Estimations for the Development of the Pharmaceutical Composition Phytoladaptogene Cytotoxic for Bladder Cancer Cells. Biochem. Moscow Suppl. Ser. B 15, 290–300 (2021). https://doi.org/10.1134/S1990750821040041

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S1990750821040041

Keywords:

Search

Navigation